| Net Cash Provided by (Used in) Operating Activities |
$-1,341,000 |
USD |
96.2% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$19,848,000 |
USD |
-67.2% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$24,467,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,416,000,000 |
shares |
18.2% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
1,118,291,159 |
shares |
27.7% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$43,162,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$968,929,000 |
USD |
22.7% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,011,267,000 |
USD |
11.9% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability |
$25,275,000 |
USD |
17.9% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$-2,151,248,000 |
USD |
-930% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$32,337,000 |
USD |
19.8% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
$5,895,000 |
USD |
30.3% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$5,916,000 |
USD |
8.77% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$6,931,000 |
USD |
13.8% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$7,062,000 |
USD |
27.5% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$2,941,000 |
USD |
-35.2% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$2,846,000 |
USD |
-28.8% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$42,338,000 |
USD |
-62.7% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$22,424,000 |
USD |
-26.3% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |